August 1, 2012
Bookmark and Share  
 
                 
  HCV
»
»
»
»

 

Greetings:

A special shout to Kathleen Koechlin, Ohio's Adult Viral Hepatitis Coordinator, and the people who attended the Basic and Advanced HCV Training workshops we conducted last week. It was a privilege to provide everyone with the knowledge that will help them in their mission to provide so badly needed support and services for the hepatitis C community.

In this week's eblast we have the following items newly posted to our websites:

1. August 2012 HCV Advocate

In This Issue:

  • Cure: Really? by Alan Franciscus, Editor-in-Chief – read a summary from a study that addresses scientifically whether successful treatment of HCV is really a cure.

  • HCV Snapshots by Lucinda K. Porter, RN – read about the benefits of treatment even without a cure, the effect of insulin resistance on fibrosis progression, how higher ribavirin dose affects re-treatment, and a study on the prevalence of HCV among the homeless population in Los Angeles.

  • Disability & Benefits: What Happens When COBRA Ends by Jacques Chambers, CLU – discusses what you need to know about COBRA.

  • HealthWise: Medically-Acquired Hepatitis C by Lucinda K. Porter, RN – about the Exeter Hospital outbreak and medical errors in general.

  • HCV Increases the Risk of Non-Liver Deaths by Alan Franciscus, Editor-in-Chief – this first of its kind study looks at deaths in people with hepatitis C and documents the increases in non-liver deaths in people with hepatitis C.

  • Curing Fatigue with Treatment by Alan Franciscus, Editor-in-Chief – fatigue is the most common symptom of people with hepatitis C --this study is the first to show that HCV treatment can improve fatigue including the severe fatigue that some experience.

2. HBV Journal Review by Christine Kukka – in this month's Review Chris discusses the following news and journal items:

  • Few Restrictions Recommended for HBV-Infected Doctors and Medical Students

  • Hepatitis B Continues to Be Under-Diagnosed and Under-Treated in the U.S.

  • Only 6% of Patients at Risk of Liver Cancer Are Properly Screened in the U.S.

  • Treatment with Potent Antivirals Prolong Life and Is Cost-Effective

  • U.S. Patients Follow Doctors’ Order and Take Antivirals as Prescribed

  • Experts Suggest "Healthy" ALT Levels Should Be Lowered to 17 and 21 IU/L

  • Hepatitis B Does Not Impact Quality of Life until Severe Cirrhosis or Liver Cancer Occur

  • Another Study Shows Interferon Effective in Patients with HBV Genotype B

  • New Study Confirms the Safety of Antiviral Treatment in Pregnant Women

  • Vitamin B12 Helps Hepatitis C Patients Treated with Interferon and Antiviral

  • Vitamin E May Decreases Liver Cancer Risk

3. Factsheets and Guideswe continue to update our fact sheets and guides. 

Check out these newly updated fact sheets:

and don’t forget our updated “Treatment Issues Guides,” such as

 

4. Training ScheduleDon’t forget to keep checking our Upcoming Training Workshop Schedules to see if we will be in your neighborhood soon!

HCV

HBV

Don’t forget that there is help as close as a phone call – the 877-HELP-4-HEP line (877-435-7443) is available 9:00am to 7:00pm Eastern Time.  For more information about the services they offer either call or visit their Website at www.help4hep.org  The helpline is run by The Support Partnership:  a group of non-profits working together to help people affected by hepatitis C. 

.

5. Top News (Blog) from the hepatitis blog includes: 

Drug users fuel rise in number of Blackburn and Darwen Hepatitis C cases
July 31

The good, the bad and chronic hepatitis
July 31

Vertex Announces Positive Results from Viral Kinetic Study of the Nucleotide Analogue ALS-2200 in People with Hepatitis C
July 30

4 Michigan Facilities Linked to Hepatitis C Investigation
July 30

In Memoriam: John Plater
July 30

Presidential Proclamation -- World Hepatitis Day, 2012
July 30

Foreign media disclose hepatitis numbers on World Hepatitis Day 2012
July 30

Canceled Hepatitis C Tests Flame 'Serial Infector' Fears
July 29

10 to 12 million Pakistanis infected with hepatitis B and C
July 29

Event highlights hepatitis dangers
July 29

Washington Call for Access to HCV Diagnostics, Treatment and Care for All!
July 29

Finland: 1,000 cases of hepatitis-C diagnosed annually
July 28

World Hepatitis Day, 28 July 2012
July 28

OraSure Technologies Supports Rapid HCV Testing Initiatives for World Hepatitis Day
July 27

Pennsylvania hospitals to conduct hepatitis C testing
July 26

Hepatitis C suspect tied to Phoenix hospitals
July 26

Decompensated liver disease more frequent in HIV/HCV co-infected people
July 26

Boomers beware: Hepatitis a silent pandemic in Mendocino County
July 25

Rising numbers of hepatitis C patients treated for liver disease
July 25

Ligand Partner GlaxoSmithKline Announces Priority Review for Supplemental New Drug Application for Promacta(R) for the Treatment of Thrombocytopenia in Adult Patients with Chronic Hepatitis C Infection
July 25

IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
July 25

World Hepatitis Alliance Welcomes New Global Framework Aimed at Saving the Lives of Millions Living With Hepatitis
July 24

Official: 6,000 more people to be tested for hepatitis C
July 24

CDC: Hepatitis C suspect Kwiatkowski worked in eight states
July 24

NIH Scientists Identify Likely Predictors of Hepatitis C Severity
July 23

Michigan Among Seven States Wrapped Up in Hepatitis C Probe
July 23

Many Canadians can now be cured of hepatitis C but more trained nurses and doctors are needed
July 23

Vibrio Warning: Europe
July 22

Shirked duty alleged in hep C nightmare
July 22

Kansas hospital warns patients about hepatitis C
July 21

6 other states check for hepatitis
July 21

Canadian HCV management guidelines released
July 21

 

 and much, much more…..

 

Sincerely,

Alan

Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org

**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org

**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.

 
  HBV
»
»
»